Clinical Trial Update: A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial of CX2101A enteric-coated tablets in healthy Chinese adults has completed, evaluating safety and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• CX2101A enteric-coated tablets (CX2101A)

Snippet

Sponsor: Heronova Pharmaceuticals | Conditions: COVID-19, Coronavirus Pneumonia | Phase 1 | Status: COMPLETED